NCT04500015View on ClinicalTrials.gov

Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

August 30, 2021

Conditions
IUCD Complication
Interventions
DRUG

INH

3 vaginal tablet of isonicotinic acid hydrazide self-inserted by the patient 12 hours before IUD insertion.

DRUG

Placebo Comparator

3 tablet of placebo self-inserted by the patient 12 hours before IUD insertion.

Trial Locations (1)

81528

Aswan University Hospital, Aswān

All Listed Sponsors
lead

Aswan University Hospital

OTHER

NCT04500015 - Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion | Biotech Hunter | Biotech Hunter